ZBH (STOCKS)
Zimmer Biomet Holdings, Inc.
$88.260000
-0.310000 (-0.35%)
Prev close: $88.570000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Ivan Tornos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $17,075.00M
- Employees
- 17,000
- P/E (TTM)
- 23.00
- P/B (TTM)
- 1.35
- Dividend Yield
- 108.39%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $8.41B |
| Benefits Costs and Expenses | $7.51B |
| Cost Of Revenue | $2.52B |
| Costs And Expenses | $7.23B |
| Gross Profit | $5.89B |
| Operating Expenses | $4.71B |
| Selling, General, and Administrative Expenses | $3.35B |
| Depreciation and Amortization | $1.11B |
| Other Operating Expenses | $252.20M |
| Operating Income/Loss | $1.18B |
| Income/Loss From Continuing Operations After Tax | $760.80M |
| Income/Loss From Continuing Operations Before Tax | $903.10M |
| Income Tax Expense/Benefit | $142.30M |
| Interest Income/Expense After Provision For Losses | -$295.40M |
| Interest Income/Expense Operating, Net | -$295.40M |
| Net Income/Loss | $760.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$400.00K |
| Net Income/Loss Attributable To Parent | $761.10M |
| Net Income/Loss Available To Common Stockholders, Basic | $761.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $3.87 |
| Diluted Earnings Per Share | $3.86 |
| Basic Average Shares | 590,700,000 |
| Diluted Average Shares | 592,600,000 |
| Assets | $22.72B |
| Current Assets | $4.96B |
| Inventory | $2.25B |
| Other Current Assets | $2.72B |
| Noncurrent Assets | $17.76B |
| Fixed Assets | $2.21B |
| Intangible Assets | $4.55B |
| Other Non-current Assets | $11.00B |
| Liabilities | $10.04B |
| Current Liabilities | $2.86B |
| Accounts Payable | $361.20M |
| Wages | $293.90M |
| Other Current Liabilities | $2.21B |
| Noncurrent Liabilities | $7.18B |
| Equity | $12.68B |
| Equity Attributable To Noncontrolling Interest | $8.20M |
| Equity Attributable To Parent | $12.67B |
| Liabilities And Equity | $22.72B |
| Net Cash Flow From Operating Activities | $1.67B |
| Net Cash Flow From Operating Activities, Continuing | $1.67B |
| Net Cash Flow From Investing Activities | -$2.03B |
| Net Cash Flow From Investing Activities, Continuing | -$2.03B |
| Net Cash Flow From Financing Activities | -$618.60M |
| Net Cash Flow From Financing Activities, Continuing | -$618.60M |
| Net Cash Flow | -$973.60M |
| Net Cash Flow, Continuing | -$973.60M |
| Comprehensive Income/Loss | $857.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $857.90M |
| Other Comprehensive Income/Loss | $96.80M |
| Other Comprehensive Income/Loss Attributable To Parent | $96.80M |